Medicenna Therapeutics Corp. (TSX:MDNA)
Canada flag Canada · Delayed Price · Currency is CAD
0.3500
+0.0050 (1.45%)
Jul 24, 2026, 3:57 PM EST

Medicenna Therapeutics Balance Sheet

Millions CAD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
6.2524.8416.9833.620.54
Cash & Short-Term Investments
6.2524.8416.9833.620.54
Cash Growth
-74.83%46.26%-49.45%63.60%-49.15%
Other Receivables
1.352.71.160.861.31
Total Trade Receivables
1.352.71.160.861.31
Other Current Assets
0.720.640.931.931.55
Total Current Assets
8.3228.1719.0836.3923.39
Net Property, Plant & Equipment
0.090.16---
Other Intangible Assets
0.050.050.060.060.07
Total Assets
8.4528.3819.1336.4523.46

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
5.44.392.863.82.62
Current Portion of Leases
0.070.05---
Total Current Liabilities
5.474.442.863.82.62
Long-Term Leases
0.050.12---
Other Long-Term Liabilities
0.454.7311.083.16-
Total Long-Term Liabilities
0.514.8511.083.16-
Total Liabilities
5.979.2913.946.962.62

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
126.26126.13100.92100.9283.67
Additional Paid-in Capital
12.7311.2210.79.497.93
Accumulated Other Comprehensive Income
0.1600.020.060.17
Retained Earnings
-136.66-118.25-106.45-80.98-70.93
Shareholders' Equity
2.4819.15.1929.4920.84
Total Liabilities & Equity
8.4528.3819.1336.4523.46

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
0.120.17000
Net Cash (Debt)
6.1324.6716.9833.620.54
Net Cash Growth
-75.14%45.27%-49.45%63.60%-49.11%
Net Cash Per Share
0.070.320.240.520.38
Book Value
2.4819.15.1929.4920.84
Book Value Per Share
0.030.250.070.460.38
Tangible Book Value
2.4419.045.1329.4320.77
Tangible Book Value Per Share
0.030.250.070.450.38